SCHEMBL30938930

SCHEMBL30938930

COC(=O)c1ccc(F)c2c1nc(C)n2CC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ SENP6 Q9GZR1 1/20 0.34
▸ PLA2G7 Q13093 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ CACNA1B Q00975 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HK1 P19367 1/20 0.33
▸ HKDC1 Q2TB90 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24744893 0.89 KDM4E (0.37) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL31090538 0.89 KDM4E (0.37) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL30938924 0.89 KDM4E (0.37) KDM4EALDH1A1JAK2JAK1JAK3
SCHEMBL31090655 0.88 TLR7 (0.37) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL24742725 0.88 TLR7 (0.37) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL24744910 0.87 ATR (0.37) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL24742722 0.87 JAK2 (0.41) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL24744900 0.82 ALDH1A1 (0.38) TLR7KDM4EALDH1A1JAK2JAK1
SCHEMBL24744762 0.80 PKN1 (0.47) KDM4EALDH1A1SMN1; SMN2PTGER4MAPT
SCHEMBL29893726 0.80 PKN1 (0.47) KDM4EALDH1A1SMN1; SMN2PTGER4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 — — EP disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 — — WO disclosed
Send feedback